Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intelligent Fingerprinting
Norwich, England, United Kingdom
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
The Intelligent Fingerprinting Drug Screening System is a CE-marked device commercially deployed internationally, with over 1,000 readers in use and >450 active accounts; FDA 510(k) clearance is pending for US commercialization in 2025. The platform delivers results in under ten minutes using lateral flow technology to detect recent drug use in fingerprint sweat samples[2][6][1][7].
- Therapeutic areas
- NeurologyPsychiatryOther
- Modalities
- DeviceDiagnostic device
- Industry
- Metabolite Diagnostics
02
Partnerships
Racing Analytical Services Limited (RASL) for accredited confirmatory laboratory testing[5]
Beyond the preview
Go deeper on Intelligent Fingerprinting.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Intelligent Fingerprinting.